Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory ...

In looking across the past four years of regulatory decisions, we noticed that some of the analyses involving the European Medicines Agency (EMA)'s cycle time used an inappropriate endpoint ...

The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...

Newly-published European Commission legislation set to come into force this month lays down regulations for ground-handling ...

While there is a new focus on deregulation and simplification for regulators globally, the regulatory landscape is likely to ...

Bringing Meta AI to Europe involved "almost a year of intensive engagement with various European regulators," the company ...

The agency advises patients to confirm that any cell, gene, or tissue therapy they receive is approved by a regulator or authorized for use in a clinical trial.